查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825500

2025年全球胜肽合成市场报告

Peptide Synthesis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年肽合成市场将强劲成长，到2029年将达到89.2亿美元，复合年增长率为9.6%。预测期内的成长可归因于治疗性胜肽的快速增长、客製化胜肽需求的不断增长、其在药物发现和开发中日益重要的作用，以及对胜肽库筛检的关注。预测期内的主要趋势包括胜肽模拟物的开发、新型胺基酸衍生物的应用、胜肽环化技术、固相胜肽合成 (SPP) 的创新以及点击化学的应用。

未来五年预测成长率为9.6%，较我们先前的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国药物研发，因为这会增加来自瑞士和中国的自动化胜肽合成仪和胺基酸试剂的成本，减缓胜肽类治疗方法的研究，并提高生物技术研发成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，其影响也将更加广泛。

慢性病盛行率的上升预计将推动胜肽合成市场的未来成长。慢性病是指长期健康状况或非传染性疾病 (NCD)，通常逐渐发展。肽合成在治疗慢性病方面发挥重要作用，因为某些胜肽具有抗发炎和抗氧化特性，可能有助于预防心血管疾病和其他疾病。透过靶向特定的细胞过程和信号通路，胜肽治疗方法。例如，2024 年 6 月，澳洲政府机构澳洲健康与福利研究所报告称，2022 年慢性病的年龄标准化死亡率为每 10 万人 490 人，高于 2021 年的每 10 万人 459 人。因此，慢性病盛行率的上升正在推动胜肽合成市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球胜肽合成：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球胜肽合成市场：增长率分析
  • 全球胜肽合成市场表现：规模与成长，2019-2024
  • 全球胜肽合成市场预测：规模与成长，2024-2029年，2034年
  • 全球胜肽合成：总目标市场（TAM）

第六章 市场细分

  • 全球胜肽合成市场（依产品及服务、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 试剂
  • 装置
  • 服务
  • 全球胜肽合成市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 固相胜肽合成
  • 液相胜肽合成
  • 杂交和重组技术
  • 全球胜肽合成市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 契约製造组织 (CDMO) 和合约研究组织 (CRO)
  • 学术研究机构
  • 全球胜肽合成市场：按试剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胺基酸
  • 耦合试剂
  • 保护基团
  • 裂解试剂
  • 全球胜肽合成市场：按仪器类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 胜肽合成仪
  • 层析法系统
  • 质谱仪
  • 其他分析仪器
  • 全球胜肽合成市场：依服务类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 客製化胜肽合成
  • 胜肽表征与分析
  • 胜肽修饰服务
  • 咨询和支援服务

第七章 区域和国家分析

  • 全球胜肽合成市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球胜肽合成市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 胜肽合成市场：竞争格局
  • 胜肽合成市场：公司简介
    • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • Kaneka Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Uno Minda
  • Guizhou Xinbang Pharmaceutical Co. Ltd.
  • Hybio Pharmaceutical Co. Ltd.
  • GenScript Biotech
  • Bachem Holding AG
  • Syngene International
  • PolyPeptide Group AG
  • Mesa Labs Inc.
  • CPC Scientific Inc.
  • New England Peptide Inc.
  • Biotage
  • ScinoPharm Taiwan Ltd
  • MP Biomedicals
  • USV Private Limited
  • CEM Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年胜肽合成市场：提供新机会的国家
  • 2029年胜肽合成市场：细分领域带来新机会
  • 2029年胜肽合成市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r28714u

Peptide synthesis is the laboratory process of producing peptides, which are short chains of amino acids linked together by chemical bonds. These synthesized peptides find various applications in research, drug development, and medical diagnostics, particularly for generating precise sequences that mimic epitopes within specific protein domains.

The primary types of products and services involved in peptide synthesis include reagents, equipment, and services. Reagents in peptide synthesis are chemical compounds or substances used in the creation of peptides. Various technologies are employed in this process, including solid-phase peptide synthesis, solution-phase peptide synthesis, and hybrid and recombinant technology. These products and services are utilized by several end-users, including pharmaceutical and biotechnology companies, contract manufacturing and development organizations (CDMOs) and contract research organizations (CROs), as well as academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The peptide synthesis market research report is one of a series of new reports from The Business Research Company that provides peptide synthesis market statistics, including peptide synthesis industry global market size, regional shares, competitors with a peptide synthesis market share, detailed peptide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the peptide synthesis industry. This peptide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptide synthesis market size has grown strongly in recent years. It will grow from $5.69 billion in 2024 to $6.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rise in peptide-based vaccines, growth in biotechnology and biopharmaceuticals, demand for high-purity peptides, regulatory approvals and standardization.

The peptide synthesis market size is expected to see strong growth in the next few years. It will grow to $8.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rapid growth in therapeutic peptides, increasing demand for customized peptides, growing role in drug discovery and development, focus on peptide libraries for screening. Major trends in the forecast period include development of peptide mimetics, adoption of novel amino acid derivatives, peptide cyclization techniques, innovations in solid-phase peptide synthesis (SPPs), utilization of click chemistry.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. drug development by increasing the cost of automated peptide synthesizers and amino acid reagents sourced from Switzerland and China, thereby slowing research into peptide-based therapies and elevating biotech research and development expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is expected to drive the growth of the peptide synthesis market moving forward. Chronic diseases are long-term health conditions or non-communicable diseases (NCDs) that persist over extended periods and often develop gradually. Peptide synthesis plays a key role in addressing chronic diseases, as certain peptides possess anti-inflammatory and antioxidant properties that may help prevent conditions such as cardiovascular diseases. By targeting specific cellular processes and signaling pathways, peptides offer new therapeutic and management options for chronic diseases. For example, in June 2024, the Australian Institute of Health and Welfare, a government agency based in Australia, reported that in 2022, the age-standardized death rate due to chronic conditions was 490 per 100,000 people, an increase from 459 per 100,000 in 2021. As a result, the growing incidence of chronic diseases is driving the expansion of the peptide synthesis market.

The growth in healthcare expenditure is anticipated to accelerate the development of the peptide synthesis market. Healthcare expenditure is a broad measure that encompasses the financial resources allocated to healthcare services, medical treatments, public health programs, and the overall healthcare system. The high costs associated with peptide molecules in the pharmaceutical and nutrition sectors are attributed to their therapeutic potential, specificity, and low toxicity. For instance, in December 2023, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, U.S. healthcare spending increased by 4.1% in 2022, totaling $4.5 trillion, surpassing the 3.2% increase seen in 2021. Therefore, the rise in healthcare expenditure is propelling the growth of the peptide synthesis market.

Major companies in the peptide synthesis market are strategically focusing on introducing advanced peptide synthesizers to gain a competitive edge. Notably, Gyros Protein Technologies launched the PurePep Sonata+ peptide synthesizer in March 2022, offering enhanced efficiency, speed, and accuracy compared to traditional synthesizers. This innovative technology incorporates real-time flow monitoring, ensuring precise and accurate fluid transfers across a diverse range of viscosities.

In May 2023, Biosynth International, Inc., a Swiss-based chemical manufacturing company, acquired Cambridge Research Biochemicals to strengthen its peptide division. This acquisition brings CRB's expertise in intricate peptide chemistry and fluorescent dye labeling, enhancing Biosynth's capabilities in the peptide synthesis market.

Major companies operating in the peptide synthesis market report are Thermo Fisher Scientific, Novo Nordisk A/S, Merck KGaA, Lonza Group, Kaneka Corporation, Uno Minda, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, Mesa Labs Inc., CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd., MP Biomedicals, USV Private Limited, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

North America was the largest region in the peptide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptide synthesis market consists of revenues earned by entities by providing synthesis optimization, chemical ligation technology, and group strategy protection. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptide synthesis market also includes sales of building blocks, chelators, coupling reagents, protecting reagents, amino acids, and resins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptide Synthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptide synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The peptide synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Reagents; Equipment; Services
  • 2) By Technology: Solid-Phase Peptide Synthesis; Solution-Phase Peptide Synthesis; Hybrid And Recombinant Technology
  • 3) By End User: Pharmaceutical And Biotechnology companies; Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs); Academic And Research Institutes
  • Subsegments:
  • 1) By Reagents: Amino Acids; Coupling Reagents; Protecting Groups; Cleavage Reagents
  • 2) By Equipment: Peptide Synthesizers; Chromatography Systems; Mass Spectrometers; Other Analytical Instruments
  • 3) By Services: Custom Peptide Synthesis; Peptide Characterization And Analysis; Peptide Modification Services; Consulting And Support Services
  • Companies Mentioned: Thermo Fisher Scientific; Novo Nordisk A/S; Merck KGaA; Lonza Group; Kaneka Corporation; Uno Minda; Guizhou Xinbang Pharmaceutical Co. Ltd.; Hybio Pharmaceutical Co. Ltd.; GenScript Biotech; Bachem Holding AG; Syngene International; PolyPeptide Group AG; Mesa Labs Inc.; CPC Scientific Inc.; New England Peptide Inc.; Biotage; ScinoPharm Taiwan Ltd; MP Biomedicals; USV Private Limited; CEM Corporation; Enamine Ltd.; Creative Diagnostics; AnaSpec Inc.; CSBio Company Inc.; Alfa Chemistry; Advanced ChemTech; Gyros Protein Technologies AB; AAPPTec LLC; Biosynth International Inc.; ProteoGenix
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peptide Synthesis Market Characteristics

3. Peptide Synthesis Market Trends And Strategies

4. Peptide Synthesis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Peptide Synthesis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Peptide Synthesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Peptide Synthesis Market Growth Rate Analysis
  • 5.4. Global Peptide Synthesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Peptide Synthesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Peptide Synthesis Total Addressable Market (TAM)

6. Peptide Synthesis Market Segmentation

  • 6.1. Global Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Equipment
  • Services
  • 6.2. Global Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solid-Phase Peptide Synthesis
  • Solution-Phase Peptide Synthesis
  • Hybrid And Recombinant Technology
  • 6.3. Global Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology companies
  • Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs)
  • Academic And Research Institutes
  • 6.4. Global Peptide Synthesis Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amino Acids
  • Coupling Reagents
  • Protecting Groups
  • Cleavage Reagents
  • 6.5. Global Peptide Synthesis Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peptide Synthesizers
  • Chromatography Systems
  • Mass Spectrometers
  • Other Analytical Instruments
  • 6.6. Global Peptide Synthesis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Custom Peptide Synthesis
  • Peptide Characterization And Analysis
  • Peptide Modification Services
  • Consulting And Support Services

7. Peptide Synthesis Market Regional And Country Analysis

  • 7.1. Global Peptide Synthesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Peptide Synthesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peptide Synthesis Market

  • 8.1. Asia-Pacific Peptide Synthesis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peptide Synthesis Market

  • 9.1. China Peptide Synthesis Market Overview
  • 9.2. China Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peptide Synthesis Market

  • 10.1. India Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peptide Synthesis Market

  • 11.1. Japan Peptide Synthesis Market Overview
  • 11.2. Japan Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peptide Synthesis Market

  • 12.1. Australia Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peptide Synthesis Market

  • 13.1. Indonesia Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peptide Synthesis Market

  • 14.1. South Korea Peptide Synthesis Market Overview
  • 14.2. South Korea Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peptide Synthesis Market

  • 15.1. Western Europe Peptide Synthesis Market Overview
  • 15.2. Western Europe Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peptide Synthesis Market

  • 16.1. UK Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peptide Synthesis Market

  • 17.1. Germany Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peptide Synthesis Market

  • 18.1. France Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peptide Synthesis Market

  • 19.1. Italy Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peptide Synthesis Market

  • 20.1. Spain Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peptide Synthesis Market

  • 21.1. Eastern Europe Peptide Synthesis Market Overview
  • 21.2. Eastern Europe Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peptide Synthesis Market

  • 22.1. Russia Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peptide Synthesis Market

  • 23.1. North America Peptide Synthesis Market Overview
  • 23.2. North America Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peptide Synthesis Market

  • 24.1. USA Peptide Synthesis Market Overview
  • 24.2. USA Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peptide Synthesis Market

  • 25.1. Canada Peptide Synthesis Market Overview
  • 25.2. Canada Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peptide Synthesis Market

  • 26.1. South America Peptide Synthesis Market Overview
  • 26.2. South America Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peptide Synthesis Market

  • 27.1. Brazil Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peptide Synthesis Market

  • 28.1. Middle East Peptide Synthesis Market Overview
  • 28.2. Middle East Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peptide Synthesis Market

  • 29.1. Africa Peptide Synthesis Market Overview
  • 29.2. Africa Peptide Synthesis Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Peptide Synthesis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Peptide Synthesis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peptide Synthesis Market Competitive Landscape And Company Profiles

  • 30.1. Peptide Synthesis Market Competitive Landscape
  • 30.2. Peptide Synthesis Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Kaneka Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Peptide Synthesis Market Other Major And Innovative Companies

  • 31.1. Uno Minda
  • 31.2. Guizhou Xinbang Pharmaceutical Co. Ltd.
  • 31.3. Hybio Pharmaceutical Co. Ltd.
  • 31.4. GenScript Biotech
  • 31.5. Bachem Holding AG
  • 31.6. Syngene International
  • 31.7. PolyPeptide Group AG
  • 31.8. Mesa Labs Inc.
  • 31.9. CPC Scientific Inc.
  • 31.10. New England Peptide Inc.
  • 31.11. Biotage
  • 31.12. ScinoPharm Taiwan Ltd
  • 31.13. MP Biomedicals
  • 31.14. USV Private Limited
  • 31.15. CEM Corporation

32. Global Peptide Synthesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptide Synthesis Market

34. Recent Developments In The Peptide Synthesis Market

35. Peptide Synthesis Market High Potential Countries, Segments and Strategies

  • 35.1 Peptide Synthesis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Peptide Synthesis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Peptide Synthesis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer